---

Pde-5 inhibitors: are they enough for erectile dysfunction?

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Piyush desai*

Volume : 2, Issue : 4, Year : 2019

Article Page : 100-103

https://doi.org/10.18231/j.ijnmhs.2019.020

Suggest article by email

Get Permission

Abstract

Erectile dysfunction is a part of broader sexual dysfunction which also includes decreases libido and premature ejaculation. The Massachusetts Male Aging Study (MMAS) found that 52% of men between 40 and 70 years old reported having some form of Erectile Dysfunction (ED).¹ Medical conditions, such as hypertension, diabetes mellitus, and Cardiovascular Disease (CVD), and psychological conditions, such as depression and anxiety, also contribute to sexual dysfunction in middle-aged elderly men. Neurological disorders such as cerebral diseases, spinal cord injuries and peripheral neuropathies contribute to the ED in some patients. Hormonal disorders such as hypogonadism, vascular disorders such as atherosclerosis and peripheral vascular diseases also causes ED. Drugs implicated as a cause of ED include hydrochlorothiazides and beta-blocking agents

 

Keywords: Administered in the context of an IRB-approved experimental clinical research protocol.

How to cite : Desai P, Pde-5 inhibitors: are they enough for erectile dysfunction?. J Nutr Metab Health Sci 2019;2(4):100-103

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.